MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis
Aging · 2023
DOI: 10.18632/aging.204795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Hongliang Ou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Diseases, Ningbo No.2 Hospital, University of Chinse Academy of Sciences, Ningbo 315000, Zhejiang, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, MicroRNAs, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Diseases, Ningbo No.2 Hospital, University of Chinse Academy of Sciences, Ningbo 315000, Zhejiang, P.R. China.
Zitieren
APA
Ou, H., Qian, Y., & Ma, L. (2023). MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis. Aging. https://doi.org/10.18632/aging.204795
Vancouver
Ou H, Qian Y, Ma L. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis. Aging. 2023. doi:10.18632/aging.204795
BibTeX
@article{Ou2023,
author = {Ou, Hongliang and Qian, Yunsong and Ma, Li},
title = {MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204795}
}
EUVIMED